According to the Latin America Multiplex Assays Market Research Report, is anticipated to grow at a 6.95% CAGR from 2016 to 2021 and it is estimated that the Latin-America market was valued at USD 0.32 billion in 2016 and is expected to reach USD 0.45 billion by 2021.
Browse market data tables and in-depth TOC of the Latin America Multiplex Assays Market to 2021 @ http://www.marketdataforecast.com/market-reports/latin-america-multiplex-assays-market-5011/
While multiplex bead array assays (MBAA) are widely ascribed to be a recent innovation, descriptions of these assays can be found in the literature as far back as 1977. A wide assortment of tests has been devised for MBAA using both immunological and molecular ligands. The potential advantages of these assays are apparent, such as the ability to independently and quantitatively assay multiple analytes simultaneously in small volumes of material and the collection of data from numerous beads for each ligand to provide statistical rigor. The potential cost- and time-savings that could be accrued by use of MBAA in comparison to other methods provides a strong impetus for the routine use of these in both the research and clinical laboratories. As with all clinical laboratory tests, questions of reproducibility, precision, and accuracy must be addressed in order to validate these assays. This commonly involves a comparison to methods considered to be the current standards.
Factors such as increasing number of research & development for treatment of diseases, rising adoption of multiplex assays to reduce operation costs, technological advancements, and growth in adoption of personalized medicine for increasing safety & efficacy of therapies are expected to create new opportunities for the main players during the analysis period. However, lack of experienced healthcare professionals and huge capital investments are the major restrains for the market growth.
This is can be attributed to the increase in the geriatric population, rise in the prevalence of cataract, and rise in the government initiatives to eliminate avoidable blindness. Moreover, rise in adoption of premium lens due to their enhanced visual performance ensures reduced rates of astigmatism, thus boosting the growth of the market. However, unfavorable reimbursement schemes and postoperative complications such as refractive errors are anticipated to have a negative impact on the market growth.
The Latin America Multiplex Assays Market Segmentation into Product, Technology, Type, Application and End User. On the basis of product, it is segmented into Consumable, Kits & Reagents and Panels. The consumables sub-segment is projected to account for the largest share of the products segment due to increase in the demand of consumables. On the basis of Technology, it is segmented into PCR and Multiplex Array. The multiplex array is further segmented into planar arrays and bead-based arrays. The multiplex arrays segment is projected to hold the largest share of the multiplex assays market. On the basis of Type, it is segmented into Nucleic Acid-Based and Protein-Based. Nucleic acid-based assays segment is further classified into planar nucleic acid assays and bead-based nucleic acid assays. Protein-based assays segment is further categorized into planar protein assays and bead-based protein assays. The protein based assays segment is expected to witness the fastest growing segment of the multiplex assays market. On the basis of Application, it is segmented into R&D and Companion Diagnostics. The research & development segment is estimated to account for the largest share of the multiplex assays market. On the basis of End User, it is segmented into Hospital and Clinical Laboratory. The pharmaceutical and biotechnology companies segment is expected to account for the largest share.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/latin-america-multiplex-assays-market-5011/request-sample
On the basis of geography, the market is analyzed under various regions namely Argentina, Brazil and Mexico. Poor economies and strict government policies are going to impact the market growth negatively. However, heavy investment by private players in the untapped market are going to boost the market growth.
Latin America Multiplex Assays Industry key players are Luminex Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Abcam Plc, Becton, Dickinson and Company, Luminex Corporation, Meso Scale Diagnostics, Randox Laboratories Ltd and Seegene Inc.
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: [email protected]
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases